Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2012
http://purl.obolibrary.org/obo/NCIT_C2012
|
|---|---|
| Preferred Name | Matuzumab |
| Definitions |
A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation. |
|---|---|
| label | Matuzumab
|
| prefLabel | Matuzumab
|
| Legacy Concept Name | EMD_72000
|
| in_subset | |
| Preferred_Name | Matuzumab
|
| Is_Value_For_GDC_Property | |
| Maps_To | Matuzumab
|
| PDQ_Open_Trial_Search_ID | 350433
|
| UMLS_CUI | C1328134
|
| FDA_UNII_Code | MG4M3QB242
|
| prefixIRI | NCIT:C2012
|
| NCI_Drug_Dictionary_ID | 350433
|
| Contributing_Source | FDA
|
| subClassOf | |
| code | C2012
|
| type | |
| ALT_DEFINITION | A monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. EMD 72000 binds to the epithelial growth factor receptor (EGFR) on tumor cells and blocks growth signals.
|
| PDQ_Closed_Trial_Search_ID | 350433
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Immunologic Factor
|
| CAS_Registry | 339186-68-4
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |